Evaluation and comparison of short chain fatty acids composition in gut diseases

Figure 1 Barplot of relative abundances of fecal short chain fatty acids’ of healthy controls and celiac disease, colorectal cancer, adenomatous polyposis patients.

Figure 2 Representation of each short chain fatty acid percentage in celiac disease, colorectal cancer, adenomatous polyposis patients and healthy controls. The differences between States were assessed using the Wilcoxon test. ^aP < 0.05 vs HC, ^bP < 0.01 vs HC, ^cP < 0.05 vs CRC and ^dP < 0.01 vs CRC.

Figure 3 Partial Least Squares Discriminant Analysis scores plot. PLS-DA: Partial Least Squares Discriminant Analysis; HC: Healthy control; CD: Celiac disease; CRC: Colorectal cancer; AP: Adenomatous polyposis.

Figure 4 Expected proportions from the dirichlet regression model (lines) vs short chain fatty acids’ observed values (points), color coded by state. HC: Healthy control; CD: Celiac disease; CRC: Colorectal cancer; AP: Adenomatous polyposis.